Keywords: fda, approves, fujisawa, prograf, immunosuppressant, drug, tacrolimus

FDA Approves Fujisawa's Prograf

Article | 12 May 1997

- Fujisawa's immunosuppressant drug Prograf (tacrolimus) has beenapproved in the USA for the prophylaxis of kidney transplant rejection. The product has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in